A total of 16 VLUs from 13 patients were included in this series; seven VLUs in the very large group, and nine in the smaller group.
Dressing choices to address key patient reported experience outcomes.
The aim of this systematic review was to identify and appraise the relevant clinical evidence on the use of TLC-NOSF dressings as a first-line treatment, i.e., as an integral part of SoC at first...
We have shown that the CWC rate was significantly increased in dACM-treated subjects compared with subjects treated with SoC alone in a challenging patient population with DFUs of >6 weeks' duration...
Patients included in the study had excellent oral tolerability to the drug at 5.0ml/day. Oral+topical Cytoreg had a positive effect on patients with DFUs, according to the Saint Elian system, wherein...
Miro3D Wound Matrix (Reprise Biomedical, Inc., US). There are four available sizes, as shown: 2×2cm; 3×3cm; 5×5cm; 10×5cm. All are 2cm thick.
There were 199 patients assessed for study eligibility; 80 (40%) patients did not pass screening. The main reasons for screening failure included reduction by ≥30% of the ulcer area (post debridement)...
Medicare is divided into four parts2.
In summary, the HPFD dressing prevented bacterial ingress for seven days, demonstrated significant removal of surface bacteria and sequestered the vast majority of the bioburden into the...
Cellular, acellular, and matrix-like products (CAMPs), in particular amniotic membranes (AM), represent a newer class of regenerative therapies that physically act as a skin barrier replacement, while...
‘The removal of the bandages is uncomfortable and tears my skin.’ .
Patient records from seven clinics in the Northeast, Southeast, Midwest, and Mid-Atlantic regions of the US were screened, and a total of 50 patients met inclusion criteria for the study..
BJM supports midwives by sharing expertise and advice to help you build confidence, grow professionally and improve care.
Evidence-based best practice
Peer-reviewed research
Practical guidance
CPD support